Clovis Oncology (CLVS) Adds to Intra-Day Gains on Rampant M&A Chatter

September 20, 2016 4:56 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Clovis Oncology (NASDAQ: CLVS) adds to intra-day rumor-fueled gains after-hours. Shares are up 6% after-hours after gaining 12.7% intra-day on increased takeover chatter.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment